logo
logo

Orthox Closes $12.5M Series A Financing For Clinical Trials Of Knee Cartilage Repair Fibrofix™ Product Platform

Feb 09, 2022over 3 years ago

Amount Raised

$12.5 Million

Round Type

series a

OxfordHealth Care

Description

Orthox Limited, a clinical stage company developing medical implants to repair damaged knee articular cartilage and other orthopaedic injuries, announces the completion of a further $4.3m (£3.2m) to close its $12.5m (£9.2m) Series A financing round. The financing will support further clinical trials of its lead product, FibroFixTM, at Southmead Hospital Bristol, UK and in Budapest, Hungary.

Company Information

Company

Orthox

Location

Oxford, Mississippi, United States

About

Orthox is a clinical stage company developing medical devices to repair damaged cartilage and other orthopaedic injuries. Orthox's FibroFixTM technology, originating from Oxford University, is a revolutionary tissue scaffold based on fibroin, a tissue regenerative protein extracted from silk fibres. FibroFixTM implants remove only the damaged tissue, employing bone-sparing, minimally invasive surgical techniques which enable rapid patient rehabilitation. By combining superb strength and low friction with tissue regeneration FibroFixTM offers the potential for better long-term outcomes, nurturing the body's innate capacity to heal itself. FibroFixTM products have the potential to address an annual market in the knee joint alone estimated at over $2 billion. The company was spun out of Oxford University and is led by experienced medtech entrepreneurs. The company has raised over £21m, including awards from leading biomedical funding programmes including Wellcome (£2.65m in Translation Awards), the NIHR i4i Programme (£1.9m in Late Stage Product Development Awards), the UK's Innovation Agency (a £1.7m Biomedical Catalyst Fund Award) and Horizon 2020's EIC Accelerator (a €2.5m grant). Orthox employs 18 people at its site in Oxfordshire. See our website here: http://www.orthox.com/

FundzWatch™ Score

72
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech